查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1497562

病理學人工智慧市場：按組件、神經網路、應用程式和最終用戶分類 - 2024-2030 年全球預測

AI in Pathology Market by Component (Hardware, Software), Neural Network (Convolutional neural networks (CNNs), Generative adversarial networks (GANs), Recurrent neural networks (RNNs)), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

病理學人工智慧市場規模預估2023年為2,901萬美元，預估2024年將達3,336萬美元，2030年將達7,875萬美元，複合年成長率為15.33%。

病理學中的人工智慧（AI）透過整合先進的計算技術、機器學習演算法和影像分析工具來自動化診斷過程的各個方面，從而提高病理診斷的速度、準確性和效率。準確快速診斷的新興市場的開拓、需要及時診斷的癌症等慢性疾病的盛行率不斷上升，以及數位病理基礎設施的持續發展，都有力地促進了市場的成長。此外，政府也持續投資研發活動和支持性舉措，旨在加速醫療保健數位化。此外，對於許多醫療機構來說，開發和整合基於人工智慧的病理學解決方案可能成本高昂。此外，使用基於雲端基礎的解決方案共用患者資料會引發對資料外洩和未授權存取敏感資訊的擔憂。除此之外，機器學習技術和人工智慧能力的快速進步正在為市場成長創造潛在機會。此外，還可以利用區塊鏈等新技術來確保患者資料的安全儲存和傳輸。

主要市場統計
基準年[2023] 2901萬美元
預測年份 [2024] 3336萬美元
預測年份 [2030] 7875萬美元
複合年成長率（%） 15.33%

區域洞察

在美洲，人工智慧驅動的病理解決方案正在進行大量投資，以推進數位診斷。食品藥物管理局也開始批准以人工智慧為基礎的醫療設備，顯示這些技術正在獲得認可。歐盟委員會的計劃為專注於健康和護理數位轉型的計劃提供了大量資金。改善歐盟地區的醫療基礎設施為基於人工智慧的病理解決方案提供了獨特的機會。在亞太地區，領先的公司正在大力投資數位診斷。政府措施也支持該領域的研究和開發，產生了大量專利和研究出版物。此外，亞太地區新興經濟體醫療保健基礎設施的發展正在推動數位醫療保健解決方案的採用。

FPNV定位矩陣

FPNV 定位矩陣對於評估病理學人工智慧市場供應商的市場定位至關重要。此矩陣提供了對供應商的全面評估，並檢查了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一個綜合工具，可以對病理學市場人工智慧供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該領域競爭性質的寶貴見解，包括累積研究期、片段化優勢和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在病理學市場人工智慧中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地病理學數位化取得進展
      • 由於慢性病的傳播，對遠距病理學的需求不斷增加
    • 抑制因素
      • 病理學人工智慧相關的高成本
    • 機會
      • 病理學人工智慧的技術進步
      • 對個人化和客製化醫療保健的需求不斷成長
    • 任務
      • 資料隱私問題
  • 市場區隔分析
    • 組件：廣泛的病理學軟體應用程式，可實現無縫工作流程和高效資料管理
    • 神經網路：提高診斷準確性和效率將增加生成對抗網路的採用
    • 應用：廣泛利用AI在病理領域進行疾病診斷，促進疾病早期發現
    • 最終用戶：在製藥和生物技術公司中擴展病理學人工智慧以實現潛在的治療發現
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章病理學人工智慧市場：按組成部分

  • 硬體
  • 軟體

第7章病理學中的人工智慧市場神經網路

  • 卷積類神經網路（CNN）
  • 生成對抗網路（GAN）
  • 循環神經網路 (RNN)

第8章病理學人工智慧市場：按應用分類

  • 臨床工作流程
  • 疾病診斷與預後
  • 藥物發現
  • 培訓和教育

第 9 章病理學人工智慧市場：按最終用戶分類

  • 學術研究所
  • 醫院
  • 製藥和生物技術公司

第 10 章：美洲病理學人工智慧市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區病理學人工智慧市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章：歐洲、中東和非洲病理學人工智慧市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 微軟協助打造全球最大的病理學和腫瘤學成像人工智慧
    • PathAI 推出 PathExplore，這是一款由人工智慧驅動的病理學面板，可從腫瘤微環境中解鎖開拓的見解
    • Page 和 Leica Biosystems 宣布擴大合作夥伴關係，以加強影像管理和人工智慧技術在全球數位病理工作流程中的使用
  • 戰略分析和建議

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-1730A405FA4B

[189 Pages Report] The AI in Pathology Market size was estimated at USD 29.01 million in 2023 and expected to reach USD 33.36 million in 2024, at a CAGR 15.33% to reach USD 78.75 million by 2030.

Artificial intelligence (AI) in pathology integrates advanced computational techniques, machine learning algorithms, and image analysis tools to improve pathological diagnoses' speed, accuracy, and efficiency by automating various aspects of the diagnostic process. Increasing demand for accurate and quick diagnostics, the rising chronic diseases prevalence such as cancer that require timely diagnosis, and continuous developments in digital pathology infrastructure strongly contribute to the growth of the market. In addition, ongoing investments in research and development activities and supportive government initiatives aimed at promoting healthcare digitization. Furthermore, the development and integration of AI-based solutions in pathology can be an expensive affair for many healthcare organizations. Also, the usage of cloud-based solutions for sharing patient data raises concerns about data breaches and unauthorized access to sensitive information. Apart from this, rapid advancements in machine learning techniques & artificial intelligence capabilities create a potential opportunity for market growth. Additionally, emerging technologies such as blockchain can be leveraged to ensure secure storage and transfer of patient data.

KEY MARKET STATISTICS
Base Year [2023] USD 29.01 million
Estimated Year [2024] USD 33.36 million
Forecast Year [2030] USD 78.75 million
CAGR (%) 15.33%

Regional Insights

In the Americas, significant investments have been made in AI-driven pathology solutions to advance digital diagnostics. The Food and Drug Administration has also started approving AI-based medical devices, demonstrating an increasing acceptance of such technologies. The European Commission's program has provided significant funding for projects focusing on digital transformation in health and care. Improved healthcare infrastructure in the EU region presents a unique opportunity for AI-based pathology solutions. In the APAC region, major players have made significant investments in digital diagnostics. Government initiatives have also supported R&D in this sector, leading to numerous patents and research publications. Also, the development of healthcare infrastructure in the developing economies of the APAC region endorses the adoption of digital healthcare solutions.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the AI in Pathology Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing digitalization of pathology worldwide
      • Growing need for telepathology with the prevalence of chronic disease
    • Market Restraints
      • High cost associated with AI in pathology
    • Market Opportunities
      • Technological advancements in AI in pathology
      • Rising demand for personalized and customized medicine
    • Market Challenges
      • Concerns associated with data privacy
  • Market Segmentation Analysis
    • Component: Extensive software applications in pathology for seamless workflows and efficient data management
    • Neural Network: Increasing generative adversarial networks adoption due to diagnostic accuracy and efficiency
    • Application: Wide utilization of AI in pathology for disease diagnosis to facilitate early detection of diseases
    • End-User: Expansion of pathology AI in pharmaceuticals & biotechnology companies for discovering potential therapeutics
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the AI in Pathology Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the AI in Pathology Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Microsoft Collab to Build World's Largest Pathology, Oncology Imaging AI

Microsoft and healthcare technology company Paige have partnered to create image-based AI models for digital pathology and oncology, with the goal of revolutionizing cancer diagnosis and patient care. Paige has developed an AI model that has been trained on over 1 billion images from half a million pathology slides across various cancer types. This collaboration aims to expand the model to an even larger scale by incorporating up to 4 million digitized microscopy slides. [Published On: 2023-09-07]

PathAI Announces PathExplore, an AI-powered Pathology Panel to Unlock Untapped Insights from the Tumor Microenvironment

PathExplore, powered by artificial intelligence, is a groundbreaking technology that provides single-cell resolution of the tumor microenvironment from H&E whole-slide images. This innovative technology aims to unlock valuable insights into disease states, potentially leading to improved patient outcomes and more targeted oncology therapies. Unlike current technologies, PathExplore offers a unique combination of deep resolution and scalability, making it suitable for analyzing massive numbers of patient samples. [Published On: 2023-04-04]

Paige and Leica Biosystems Announce Expanded Partnership to Enhance Use of Image Management and Artificial Intelligence Technology in Global Digital Pathology Workflows

Paige and Leica Biosystems have announced an expanded partnership to enhance the utilization of digital pathology workflows. As part of this collaboration, a co-branded version of Paige's Platform was introduced, serving as the central interface connecting pathologists with Leica Biosystems hardware. This partnership provides users of Aperio GT 450 scanners with comprehensive access to Paige's suite of digital pathology software, encompassing the FullFocus viewer, the AI-powered worklist FullFolio, and a range of other AI software solutions. [Published On: 2023-03-12]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the AI in Pathology Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the AI in Pathology Market, highlighting leading vendors and their innovative profiles. These include aetherAI, Aiforia Technologies Oyj, Akoya Biosciences, Inc., Deep Bio, Inc., Evident Corporation, F. Hoffmann-La Roche Ltd., Ibex Medical Analytics Ltd., Indica Labs, Inc., Inspirata, Inc., LUMEA, Inc., MindPeak GmbH, Nucleai Inc., OptraSCAN Inc., Paige.AI, Inc., PathAI, Inc., Proscia Inc., Techcyte, Inc., Tempus Labs, Inc., Tribun Health, Visikol, Inc. by CELLINK, and Visiopharm A/S.

Market Segmentation & Coverage

This research report categorizes the AI in Pathology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Hardware
    • Software
  • Neural Network
    • Convolutional neural networks (CNNs)
    • Generative adversarial networks (GANs)
    • Recurrent neural networks (RNNs)
  • Application
    • Clinical Workflow
    • Disease Diagnosis & Prognosis
    • Drug Discovery
    • Training & Education
  • End-User
    • Academic & Research Institutes
    • Hospitals
    • Pharmaceuticals & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing digitalization of pathology worldwide
      • 5.1.1.2. Growing need for telepathology with the prevalence of chronic disease
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with AI in pathology
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in AI in pathology
      • 5.1.3.2. Rising demand for personalized and customized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with data privacy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Extensive software applications in pathology for seamless workflows and efficient data management
    • 5.2.2. Neural Network: Increasing generative adversarial networks adoption due to diagnostic accuracy and efficiency
    • 5.2.3. Application: Wide utilization of AI in pathology for disease diagnosis to facilitate early detection of diseases
    • 5.2.4. End-User: Expansion of pathology AI in pharmaceuticals & biotechnology companies for discovering potential therapeutics
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. AI in Pathology Market, by Component

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Software

7. AI in Pathology Market, by Neural Network

  • 7.1. Introduction
  • 7.2. Convolutional neural networks (CNNs)
  • 7.3. Generative adversarial networks (GANs)
  • 7.4. Recurrent neural networks (RNNs)

8. AI in Pathology Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Workflow
  • 8.3. Disease Diagnosis & Prognosis
  • 8.4. Drug Discovery
  • 8.5. Training & Education

9. AI in Pathology Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals
  • 9.4. Pharmaceuticals & Biotechnology Companies

10. Americas AI in Pathology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific AI in Pathology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa AI in Pathology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Microsoft Collab to Build World's Largest Pathology, Oncology Imaging AI
    • 13.3.2. PathAI Announces PathExplore, an AI-powered Pathology Panel to Unlock Untapped Insights from the Tumor Microenvironment
    • 13.3.3. Paige and Leica Biosystems Announce Expanded Partnership to Enhance Use of Image Management and Artificial Intelligence Technology in Global Digital Pathology Workflows
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. AI IN PATHOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. AI IN PATHOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AI IN PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AI IN PATHOLOGY MARKET DYNAMICS
  • FIGURE 7. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. AI IN PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. AI IN PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AI IN PATHOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AI IN PATHOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL AI IN PATHOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS (CNNS), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS (CNNS), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORKS (GANS), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORKS (GANS), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY RECURRENT NEURAL NETWORKS (RNNS), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY RECURRENT NEURAL NETWORKS (RNNS), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY CLINICAL WORKFLOW, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY CLINICAL WORKFLOW, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS & PROGNOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS & PROGNOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. MEXICO AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. MEXICO AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 104. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 111. CHINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 112. CHINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. CHINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. CHINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 119. INDIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 120. INDIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. INDIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. INDIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 127. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 128. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 132. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 135. JAPAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 136. JAPAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. JAPAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. JAPAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 143. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 144. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 152. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 159. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 160. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 164. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 175. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 176. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 183. THAILAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 184. THAILAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. THAILAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 188. THAILAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 191. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 192. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 209. DENMARK AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 210. DENMARK AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. DENMARK AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. DENMARK AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 217. EGYPT AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 218. EGYPT AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. EGYPT AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. EGYPT AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 225. FINLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 226. FINLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. FINLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. FINLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 233. FRANCE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 234. FRANCE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. FRANCE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 238. FRANCE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 241. GERMANY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 242. GERMANY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. GERMANY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. GERMANY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 249. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 250. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 254. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 257. ITALY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 258. ITALY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. ITALY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. ITALY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 266. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 273. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 274. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 281. NORWAY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 282. NORWAY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. NORWAY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 286. NORWAY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 289. POLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 290. POLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. POLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. POLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 297. QATAR AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 298. QATAR AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 299. QATAR AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. QATAR AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. QATAR AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 302. QATAR AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 305. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 306. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 307. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 310. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 314. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 318. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 322. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 326. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 329. SPAIN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 330. SPAIN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 331. SPAIN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 332. SPAIN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 333. SPAIN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 334. SPAIN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 337. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 338. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 339. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 340. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 341. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 342. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 346. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 348. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 350. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 353. TURKEY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 354. TURKEY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 355. TURKEY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 356. TURKEY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 357. TURKEY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 358. TURKEY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 362. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 363. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 364. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 365. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 366. UNITE